Profit Statement |
Balance Sheet |
Ratios |
Cash Flow |
Get all company financials in excel:
Get all company financials in excel:
Pivovary Staropramen has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of CZK 2,425 mil in 2016, or 27.1% of sales. That’s compared to 16.1% average margin seen in last five years.
The company netted CZK -1,291 mil in 2016 implying ROE of -9.44% and ROCE of -4.44%. Again, the average figures were -10.8% and -6.61%, respectively when looking at the previous 5 years.
Pivovary Staropramen’s net debt amounted to CZK 10,949 mil at the end of 2016, or 83.7% of equity. When compared to EBITDA, net debt was 4.52x, up when compared to average of -13.5x seen in the last 5 years.